A39 Stock Overview Develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Arjo AB (publ) Competitors Price History & Performance
Summary of share price highs, lows and changes for Arjo Historical stock prices Current Share Price SEK 3.28 52 Week High SEK 4.68 52 Week Low SEK 2.78 Beta 0.40 1 Month Change 12.33% 3 Month Change 5.81% 1 Year Change -14.32% 3 Year Change -62.92% 5 Year Change -24.91% Change since IPO 65.66%
Recent News & Updates Arjo AB (publ) to Report First Half, 2025 Results on Jul 11, 2025
Arjo AB (Publ) Announces CEO Changes Jan 15 Arjo AB (Publ) Announces Resignation of Joacim Lindoff as President
Third quarter 2024 earnings released: EPS: kr0.27 (vs kr0.30 in 3Q 2023) Oct 20 Arjo AB (publ) to Report Q1, 2025 Results on Apr 29, 2025
Arjo AB (publ) (OM:ARJO B) signed an agreement to acquire TECH MED. Sep 25 See more updates Arjo AB (publ) to Report First Half, 2025 Results on Jul 11, 2025
Arjo AB (Publ) Announces CEO Changes Jan 15 Arjo AB (Publ) Announces Resignation of Joacim Lindoff as President
Third quarter 2024 earnings released: EPS: kr0.27 (vs kr0.30 in 3Q 2023) Oct 20 Arjo AB (publ) to Report Q1, 2025 Results on Apr 29, 2025
Arjo AB (publ) (OM:ARJO B) signed an agreement to acquire TECH MED. Sep 25
Arjo AB (publ) (OM:ARJO B) agreed to acquire GerroMed GmbH. Sep 24
Second quarter 2024 earnings released: EPS: kr0.44 (vs kr0.38 in 2Q 2023) Jul 14
Arjo AB (Publ) Provides Organic Net Sales Guidance for the Full Year 2024 Jul 12
Arjo Provides Sales Guidance for the Year 2024 May 18
First quarter 2024 earnings released: EPS: kr0.48 (vs kr0.41 in 1Q 2023) Apr 24
New minor risk - Share price stability Apr 19 Arjo AB (publ) Approves the Election of Ulrika Dellby as New Member of the Board
Upcoming dividend of kr0.90 per share Apr 12
Full year 2023 earnings released: EPS: kr1.76 (vs kr1.65 in FY 2022) Mar 24
Arjo AB (Publ) Proposes Dividend, Payable on 25 April 2024 Mar 13
Dividend of kr0.90 announced Feb 04
Arjo AB (publ) to Report Fiscal Year 2023 Final Results on Mar 21, 2024 Jan 31
Full year 2023 earnings released: EPS: kr1.76 (vs kr1.64 in FY 2022) Jan 30 Arjo AB (publ) to Report Nine Months, 2024 Results on Oct 17, 2024
Independent Chairman of the Board recently bought €154k worth of stock Oct 24
Arjo AB (Publ) Provides Financial Outlook for 2023 Oct 20
Third quarter 2023 earnings released Oct 20 Arjo AB (publ) to Report Q1, 2024 Results on Apr 18, 2024
Independent Chairman of the Board recently bought €182k worth of stock Aug 13
Second quarter 2023 earnings released: EPS: kr0.37 (vs kr0.38 in 2Q 2022) Jul 14 Arjo Announces Executive Changes
Arjo AB (publ) Announces Resignation of Daniel Fäldt as CFO May 09
First quarter 2023 earnings released: EPS: kr0.35 (vs kr0.60 in 1Q 2022) Apr 20
Upcoming dividend of kr0.85 per share at 2.0% yield Apr 14
CEO, President & Director recently bought €489k worth of stock Feb 15
Independent Chairman of the Board recently bought €175k worth of stock Feb 03 Arjo AB (publ) to Report Nine Months, 2023 Results on Oct 19, 2023
Full year 2022 earnings released: EPS: kr1.64 (vs kr2.72 in FY 2021) Jan 26
Arjo AB (publ) Proposes Dividend for the Year 2022, Payable on April 27, 2023 Jan 26 Arjo AB (publ) Provides Organic Sales Guidance for the Year 2023
Investor sentiment deteriorated over the past week Dec 20
Less than half of directors are independent Nov 16
Third quarter 2022 earnings released Oct 29
Arjo AB (publ) Updates Sales Guidance for the Full Year 2022 Oct 28
Investor sentiment deteriorated over the past week Jul 21
Second quarter 2022 earnings released: EPS: kr0.38 (vs kr0.69 in 2Q 2021) Jul 15 Arjo AB (publ) to Report Q1, 2023 Results on Apr 20, 2023
CEO, President & Director recently bought €99k worth of stock Apr 30
First quarter 2022 earnings released: EPS: kr0.60 (vs kr0.64 in 1Q 2021) Apr 27
Less than half of directors are independent Apr 27
Arjo AB (publ) Approves Dividend for the Year 2021 Apr 23
Upcoming dividend of kr1.15 per share Apr 18
Now 22% undervalued after recent price drop Feb 08
CEO, President & Director recently bought €480k worth of stock Feb 06
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Feb 04 Arjo AB (publ) to Report First Half, 2022 Results on Jul 14, 2022
Arjo AB (Publ) Proposes Dividend for the Year 2021, Payable on April 29, 2022 Feb 03
Independent Director recently bought €156k worth of stock Nov 10
Third quarter 2021 earnings released Oct 29
Second quarter 2021 earnings released: EPS kr0.69 (vs kr0.42 in 2Q 2020) Jul 16
Arjo AB (Publ) Resolves to Declare A Dividend Apr 29
Arjo AB (Publ) Provides Sales Guidance for the Year 2021 Apr 28
Upcoming dividend of kr0.85 per share Apr 21
Full year 2020 earnings released: EPS kr1.93 (vs kr1.48 in FY 2019) Mar 27
CEO, President & Director recently bought €100k worth of stock Feb 25
Full year 2020 earnings released: EPS kr1.93 (vs kr1.48 in FY 2019) Feb 05
Revenue beats expectations Feb 05
New 90-day high: €6.47 Jan 11
New 90-day high: €6.43 Dec 18
Arjo AB (publ) (OM:ARJO B) acquired AirPal. Dec 03
New 90-day high: €6.05 Nov 02
Revenue beats expectations Nov 02
Third quarter earnings released Oct 30
Third-quarter earnings released: Revenue beats expectations Oct 30
Arjo AB (publ) to Report Q1, 2021 Results on Apr 27, 2021 Oct 28
Market bids up stock over the past week Oct 14
New 90-day high: €5.44 Oct 12 Bruin Biometrics, LLLC and Arjo Agree Exclusive Worldwide Distribution Rights for Pressure Ulcer Sem Scanner
Arjo Enters into Distribution Agreement with Brainlit Sep 30
New 90-day high - €5.29 Jul 30 Shareholder Returns A39 DE Medical Equipment DE Market 7D 3.3% 1.5% 2.6% 1Y -14.3% -6.0% 13.4%
See full shareholder returns
Return vs Market: A39 underperformed the German Market which returned 12.1% over the past year.
Price Volatility Is A39's price volatile compared to industry and market? A39 volatility A39 Average Weekly Movement 5.6% Medical Equipment Industry Average Movement 6.6% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.5% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: A39 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: A39's weekly volatility (6%) has been stable over the past year.
About the Company Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, prone positioning early mobility, and rehabilitation services, as well as maintenance, and equipment rental and financing solutions.
Show more Arjo AB (publ) Fundamentals Summary How do Arjo's earnings and revenue compare to its market cap? A39 fundamental statistics Market cap €884.18m Earnings (TTM ) €43.90m Revenue (TTM ) €972.14m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) A39 income statement (TTM ) Revenue SEK 11.18b Cost of Revenue SEK 6.31b Gross Profit SEK 4.87b Other Expenses SEK 4.37b Earnings SEK 505.00m
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 30, 2025
Earnings per share (EPS) 1.85 Gross Margin 43.59% Net Profit Margin 4.52% Debt/Equity Ratio 53.3%
How did A39 perform over the long term?
See historical performance and comparison Dividends
2.4% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/17 07:34 End of Day Share Price 2025/01/17 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Arjo AB (publ) is covered by 9 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution null null ABG Sundal Collier Kristofer Liljeberg-Svensson Carnegie Investment Bank AB Erik Cassel Danske Bank
Show 6 more analysts 
